Episode Description:
Loneliness. Housing instability. Food insecurity. Obesity. Chronic disease. Increasingly, these issues don't land in community centres or social services, they land in GP clinics and emergency departments.
What happens when medicine becomes the catch all for problems rooted in social fragmentation? From eight minute consultations that can't possibly solve loneliness, to pharmacists becoming surrogate community anchors, to the economics of GLP-1 drugs as population-level interventions, the panel examines where the line between health and social intervention is blurring and whether healthcare was ever designed, or can continue, to carry this load.
Key Topics:
- Healthcare "plugging the gaps" of social collapse
- Loneliness as a public health issue
- Transactional, time-limited care models
- Social prescribing and community activation
- Food access and the "Tesco intervention" story
- GLP-1s as preventative health investment
- Lifelong medication and stigma
- Lifestyle modification through pharmacology
- AI companionship and digital social support
- The rise of lifestyle medicine and neighbourhood care models
Relevant Links & Resources:
Connect with us:
- Find all things Heidi at heidihealth.com
- Connect with Heidi on LinkedIn
- Connect with Dr Tom Kelly on LinkedIn
- Connect with Christina Farr:
- Check out Christina's book 'The Storytellers Advantage'.
- Connect with Dr Hannah Allen on LinkedIn
- Connect with Dr Simon Kos on LinkedIn
Resources:
- WHO - Social Isolation and Loneliness as Public Health Priorities: https://www.who.int/teams/social-determinants-of-health/demographic-change-and-healthy-ageing/social-isolation-and-loneliness
- Social Prescribing - NHS England: https://www.england.nhs.uk/personalisedcare/social-prescribing/
- USDA Food Access Research Atlas - Food Deserts & Healthy Food Access: https://ers.usda.gov/sites/default/files/_laserfiche/publications/42711/12701_ap036b_1_.pdf
- How Japan Is Automating Elder Care (MIT Technology Review): https://www.technologyreview.com/2023/01/09/1065135/japan-automating-eldercare-robots/
- GLP-1 Medications & Prevention - Semaglutide for Obesity (STEP Trials, NEJM): https://www.nejm.org/doi/full/10.1056/NEJMoa2032183